UCLA Hematology/Oncology - Alhambra — Alhambra, California

UCLA Hematology/Oncology - Alhambra is a clinical research site located in Alhambra, California, United States 91801.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

UCLA Hematology/Oncology - Alhambra has participated in 7 clinical trials with 3 currently active.

Therapeutic areas: HER2-positive Breast Cancer, HER2 Positive Breast Cancer, Breast Cancer.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Pfizer.

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCLA Hematology/Oncology - Alhambra?

UCLA Hematology/Oncology - Alhambra has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCLA Hematology/Oncology - Alhambra conducted?

UCLA Hematology/Oncology - Alhambra has 7 clinical trials on record, with 3 currently active. Their work covers HER2-positive Breast Cancer, HER2 Positive Breast Cancer, Breast Cancer.

Is UCLA Hematology/Oncology - Alhambra accredited by Crixeo Health?

Yes — UCLA Hematology/Oncology - Alhambra holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about UCLA Hematology/Oncology - Alhambra?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.